Grafiek agenda Taiwan Liposome Company, Ltd.
Komende gebeurtenissen op Taiwan Liposome Company, Ltd.
Geen evenementen beschikbaar
Gebeurtenissen op naam
09-01-2024 23:00 | JPMorgan Healthcare Conference |
15-11-2023 17:30 | American College of Rheumatology Conference - Abstract ID:1651410 |
27-09-2021 16:00 | Cantor Virtual Global Healthcare Conference |
13-09-2021 | HC Wainwright & Co Global Investment Conference |
12-08-2021 11:44 | Eerste halfjaar 2021 Cijferpublicaties |
14-05-2021 13:32 | Q1 2021 Cijferpublicaties |
07-04-2021 | Taiwan Stock Market Discovery Forum |
22-03-2021 | International Society for Aerosols in Medicine Congress |
17-03-2021 13:00 | Oppenheimer Healthcare Conference |
09-03-2021 13:00 | H.C. Wainwright Global Life Science Conference |
05-02-2021 10:15 | Boekjaar 2020 Cijferpublicaties |
28-10-2020 09:50 | Q3 2020 Cijferpublicaties |
23-09-2020 15:10 | Oppenheimer Healthcare Fall Summit |
15-09-2020 16:00 | Cantor Global Healthcare Conference |
14-09-2020 16:00 | H.C. Wainwright & Co., LLC Global Investment Conference |
09-09-2020 14:30 | Baird Global Healthcare Conference |
05-08-2020 | Eerste halfjaar 2020 Cijferpublicaties |
13-05-2020 10:12 | Q1 2020 Cijferpublicaties |
11-02-2020 11:45 | Boekjaar 2019 Cijferpublicaties |
15-01-2020 19:00 | JP Morgan Health Care Conference |
Gebeurtenissen in het verleden in de sector Taiwan Liposome Company, Ltd.
03-05-2024 13:00 | GH RESEARCH PLC: Q1 2024 Cijferpublicaties |
02-05-2024 22:05 | KURA ONCOLOGY, INC.: Q1 2024 Cijferpublicaties |
02-05-2024 22:05 | ZYMEWORKS INC.: Q1 2024 Cijferpublicaties |
02-05-2024 22:02 | ARDELYX, INC.: Q1 2024 Cijferpublicaties |
02-05-2024 22:01 | LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Cijferpublicaties |
02-05-2024 22:01 | ASCENDIS PHARMA A/S: Q1 2024 Cijferpublicaties |
02-05-2024 22:00 | ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Cijferpublicaties |
02-05-2024 17:00 | GENMAB A/S: Q1 2024 Cijferpublicaties |
02-05-2024 13:00 | GERON CORPORATION: Q1 2024 Cijferpublicaties |
02-05-2024 13:00 | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Cijferpublicaties |